Celularity Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CELU, updated each market day.
CELU AI Sentiment
AI predicts Celularity Inc. Class A Common Stock stock is likely to increase over the next 10 market days.
Prediction date: May 20, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Celularity Inc. Class A Common Stock
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Sector
Exchange
Market Cap
$23,486,752
Cap Tier
Employees
115
Headquarters
FLORHAM PARK, NJ
Listed Since
July 19, 2021
Website
CELU Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CELU Volatility
Celularity Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
